A new targeted chemotherapy platform has just been unveiled. Designed to advance precision oncology, the technology aims to deliver chemotherapy drugs directly to tumors while sparing healthy tissue, addressing a critical challenge in cancer treatment.

It uses a dual-action mechanism that concentrates potent chemotherapy agents near tumors and neutralizes any free drug molecules that escape, preventing systemic toxicity. In-vitro studies indicate the system could enhance therapeutic effects tenfold while maintaining safety for healthy cells.

The platform is engineered to work with over 100 existing chemotherapy drugs, including generic agents and compounds previously considered too toxic for broad use.

It achieves tumor-selective release by activating drugs only under specific tumor conditions, ensuring concentrated anti-cancer activity where needed. Escaped drug molecules are trapped, rendered inert, and can be recirculated back to the tumor for re-release, further protecting healthy tissue.

Source.